Quantitation of Cannabidiol (CBD) in brain regions and plasma following intranasal administration of a CBD nanoformulation

Abstract Background and objective Delivering therapeutic drugs to the brain for neurological disorders remains challenging due to the restrictive nature of the blood–brain barrier (BBB). Intranasal (IN) nanoparticle delivery may enhance the bioavailability of lipophilic cannabidiol (CBD), addressing...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Gunjan Upadhyay, Oksana Fihurka, Pranav Patel, Juan Sanchez-Ramos
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2025-08-01
Edice:	Journal of Cannabis Research
Témata:	LC–MS/MS CBD 7CBD-COOH Intranasal administration Nanofomulation Δ 9 THC
On-line přístup:	https://doi.org/10.1186/s42238-025-00308-5
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!